Spots Global Cancer Trial Database for Real-life Data of Cardiovascular Events Occuring During Degarelix Therapy for Prostate Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Real-life Data of Cardiovascular Events Occuring During Degarelix Therapy for Prostate Cancer
Official Title:
Study ID: NCT02229253
Interventions
Study Description
Brief Summary: Patients with prostate cancer and a history of cardiovascular disease treated with degarelix for their prostate cancer, will be followed for a period of one year. In this real-life, non-interventional trial, any cardiovascular events occurring during degarelix therapy will be documented.
Detailed Description:
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Groene Hart Ziekenhuis (there may be other sites in this country), Gouda, , Netherlands
Contact Details
Name: Clinical Development Support
Affiliation: Ferring Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
